Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Karyopharm Therapeutics Inc. (KPTI)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 4,827,078 $82,205 +2% 4.42%
2.
Palo Alto Investors

William Leland Edwards

4,663,324 $79,416 3.2%
3.
Birchview Capital

Matthew Strobeck

50,000 $852 0.54%
4.
Deerfield Management

James E. Flynn

475,000 $8,089 0.28%
5.
Dorset Management

David M. Knott

32,000 $545 0.17%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$33.00 2,000 Officer 3,000 2015-04-07 Filing
$29.43 1,000 Officer 1,000 2015-04-06 Filing
$29.31 3,000 Director 3,000 2015-04-02 Filing
$29.71 5,000 Officer 5,000 2015-04-02 Filing
$33.00 440 Director 21,883 2015-01-12 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$10.11 12,500 Officer, Director 713,510 2018-12-07 Filing
$10.11 12,500 Officer 713,510 2018-12-07 Filing
$11.00 9,600 Officer 512,143 2018-11-26 Filing
$11.00 9,600 Officer, Director 512,143 2018-11-26 Filing
$11.14 400 Officer 512,143 2018-11-19 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 473,901 $8,071 2.22%
2. 215,445 $3,669 1.91%
3. 119,739 $2,039 0.95%
4. 694,068 $11,820 0.43%
5. 647,307 $11,024 0.37%
News See All